The role of inflammatory cytokines in cognition and other non-motor symptoms of Parkinson's disease

Psychosomatics

Volumn 51, Issue 6, 2010, Pages 474-479

  Menza, Matthew ^a   Dobkin, Roseanne DeFronzo ^a   Marin, Humberto ^a   Mark, Margery H ^a   Gara, Michael ^a   Bienfait, Karina ^a   Dicke, Allison ^a   Kusnekov, Alex ^a  

^a RUTGERS ROBERT WOOD JOHNSON MEDICAL SCHOOL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CYTOKINE; HYDROCORTISONE; INTERLEUKIN 10; INTERLEUKIN 1BETA; INTERLEUKIN 6; TUMOR NECROSIS FACTOR ALPHA;

ADULT; AGED; ARTICLE; COGNITION; COGNITIVE DEFECT; DEPRESSION; DISABILITY; DYSTHYMIA; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; PARKINSON DISEASE; QUALITY OF LIFE; SLEEP DISORDER; SYMPTOMATOLOGY;

EID: 78649686234     PISSN: 00333182     EISSN: 15457206     Source Type: Journal    
DOI: 10.1176/appi.psy.51.6.474     Document Type: Article

References (35)

1. Jost WH: Costs in the treatment of parkinsonism. J Neurol 2000; 247(suppl 4):IV/31-33
2. McKinlay A, Grace RC, Dalrymple-Alford JC, et al: A profile of neuropsychiatric problems and their relationship to quality of life for Parkinson's disease patients without dementia. Parkinsonism Relat Disord 2008; 14:37- 42; E-pub Jul 12, 2007
3. Dantzer R, O'Connor JC, Freund GG, et al: From inflammation to sickness and depression: when the immune system subjugates the brain. Nat Rev Neurosci 2008; 9:46-56 (Pubitemid 350295688)
4. McAfoose J, Baune BT: Evidence for a cytokine model of cognitive function. Neurosci Biobehav Rev 2009; 33:355-366
5. Aarsland D, Andersen K, Larsen JP, et al: Prevalence and characteristics of dementia in Parkinson disease: an 8-year prospective study. Arch Neurol 2003;60:387-392
6. Mrak RE, Griffin WST: Potential Inflammatory biomarkers in Alzheimer's disease. J Alz Dis 2005; 8:369-375
7. Dik MG, Jonker C, Hack CE, et al: Serum inflammatory proteins and cognitive decline in older persons. Neurology 2005; 64:1371-1377 (Pubitemid 40570504)
8. Anisman H, Merali Z, Poulter MO, et al: Cytokines as a precipitant of depressive illness: animal and human studies. Curr Pharm Des 2005; 11:963-972 (Pubitemid 40331298)
9. Hayley S, Poulter MO, Merali Z, et al: The pathogenesis of clinical depression: stressor- and cytokine-induced alterations of neuroplasticity. Neuroscience 2005; 135:659-678 (Pubitemid 41407732)
10. Goshen I, Kreisel T, Ben-Menachem-Zidon O, et al: Brain interleukin-1 mediates chronic stress-induced depression in mice via adrenocortical activation and hippocampal neurogenesis suppression. Mol Psychiatry 2008; 13:717-728
11. Szelenyi J: Cytokines and the central nervous system. Brain Res Bull 2001; 54:329-338
12. Pickering M, Cumiskey D, O'Connor JJ, et al: Actions of TNF-α on glutamatergic synaptic transmission in the central nervous system. Exp Physiol 2005; 90:663-670 (Pubitemid 41406053)
13. Boka G, Anglade P, Wallach D, et al: Immunocytochemical analysis of tumor necrosis factor and its receptors in Parkinson's disease. Neurosci Lett 1994; 172:151-154
14. Chen H, Jacobs E, Schwarzschild MA, et al: Nonsteroidal antiinflammatory drug use and the risk for Parkinson's disease. Ann Neurol 2005; 58:963-967 (Pubitemid 41746889)
15. Carvey PM, Chen EY, Lipton JW, et al: Intra-parenchymal injection of tumor necrosis factor-α and interleukin 1-β produces dopamine neuron loss in the rat. J Neural Transm 2005; 112:601-612
16. Nagatsu T, Sawada M: Cellular and molecular mechanisms of Parkinson's disease: neurotoxins, causative genes, and inflammatory cytokines. Cell Mol Neurobiol 2006; 26(4-6):781-802
17. Menza M, Dobkin R, Marin H, et al: A controlled trial of antidepressants in patients with Parkinson's disease and depression. Neurology 2009; 72:886-892
18. Menza M, Dobkin R, Marin H, et al: The impact of treatment of depression on quality of life, cognition, and relapse in patients with Parkinson's disease. Mov Disord 2009; 24:9:1325-1332
19. Wechsler D: Wechsler Adult Intelligence Test, 3rd Edition. New York, Psychological Corporation, 1997
20. Kaplan EF, Goodglass H, Weintraub S: Boston Naming Test. Philadelphia, PA, Lee & Febiger, 1983
21. Wechsler D: Wechsler Memory Scale, 3rd Edition. New York, Psychological Corporation, 1997
22. Golden CJ: Stroop Color and Word Test. Wood Dale, IL, Stoelting Co, 1978, pp 1-32
23. Hekler EB, Rubenstein J, Coups EJ, et al: Inflammatory markers in acute myocardial infarction patients: preliminary evidence of a prospective association with depressive symptoms. J Appl Biobehav Res 2007, 12:65-81
24. Wilson CJ, Finch CE, Cohen HJ: Cytokines and cognition: the case for a head-to-toe inflammatory paradigm. J Am Geriatr Soc 2002; 50:2041-2056
25. Zuliani G, Ranzini M, Guerra G, et al: Plasma cytokines profile in older subjects with late onset Alzheimer's disease or vascular dementia. J Psychiatr Res 2007, 41:686-693
26. Bruunsgaard H, Andersen-Ranberg K, Jeune B, et al: A high plasma concentration of TNF-α is associated with dementia in centenarians. J Gerontol A Biol Sci Med Sci 1999; 54:M357-M64
27. Tobinick E, Gross H, Weinberger A, et al: TNF-α modulation for treatment of Alzheimer's disease: a 6-month pilot study, Med Gen Med 2006; 8:25
28. Tobinick EL, Gross H: Rapid cognitive improvement in Alzheimer's disease following perispinal etanercept administration. J Neuroinflammation 2008, 5:2
29. Hayden KM, Zandi PP, Khachaturian AS, et al: Does NSAID use modify cognitive trajectories in the elderly? The Cache County Study. Neurology 2007; 69:275-282
30. Szekely CA, Thorne JE, Zandi PP, et al: Nonsteroidal anti-inflammatory drugs for the prevention of Alzheimer's disease: a systematic review. Neuroepidemiology 2004; 23:159-169
31. Cummings JL: Depression and Parkinson's disease. Am J Psychiatry 1992; 149:443-454
32. Anisman H: Cascading effects of stressors and inflammatory immune system activation: implications for major depressive disorder. J Psychiatry Neurosci 2009; 34:4-20
33. Karlsen KH, Tanberg E, Arsland D, et al: Health related quality of life in Parkinson's disease: a prospective longitudinal study. J Neurol Neurosurg Psychiatry 2000; 69:584-589
34. Krueger JM: The role of cytokines in sleep regulation. Curr Pharm Des 2008; 14:3408-3416
35. Cavadini G, Petrzilka S, Kohler P, et al: TNF-α suppresses the expression of clock genes by interfering with E-box-mediated transcription. PNAS 2007; 104:31:12843-12848 (Pubitemid 47255242)